External Beam Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Conditions: Uterine Cervical Neoplasms; Chemoradiotherapy; Angiogenesis Interventions: Drug: Hydrochloride anlotinib; Drug: cis Platinum/carboplatin; Radiation: External beam radiotherapy and brachytherapy Sponsor: Zhongnan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 25, 2021 Category: Research Source Type: clinical trials
Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC
Condition: Advanced Hepatocellular Carcinoma Intervention: Drug: Nivolumab Sponsors: National Cancer Center, Korea; Samsung Medical Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2020 Category: Research Source Type: clinical trials
